| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.18M | 23.60M | 23.50M | 21.78M | 18.24M | 15.03M |
| Gross Profit | 14.34M | 15.03M | 15.00M | 13.85M | 11.21M | 8.80M |
| EBITDA | 153.00K | 948.00K | -604.00K | -237.00K | -1.52M | 180.00K |
| Net Income | -3.80M | -3.30M | -3.85M | -2.01M | -3.65M | -1.69M |
Balance Sheet | ||||||
| Total Assets | 49.97M | 52.29M | 49.82M | 47.36M | 39.89M | 34.64M |
| Cash, Cash Equivalents and Short-Term Investments | 1.40M | 2.87M | 1.24M | 2.33M | 2.01M | 2.18M |
| Total Debt | 35.02M | 32.92M | 27.04M | 20.66M | 10.78M | 17.43M |
| Total Liabilities | 38.62M | 37.24M | 31.55M | 25.35M | 16.01M | 21.65M |
| Stockholders Equity | 11.22M | 14.80M | 18.08M | 21.79M | 23.58M | 12.83M |
Cash Flow | ||||||
| Free Cash Flow | -1.73M | -1.75M | -7.62M | -8.98M | -5.86M | -2.12M |
| Operating Cash Flow | -961.00K | -805.00K | -5.54M | -5.63M | -4.67M | -1.02M |
| Investing Cash Flow | -599.00K | -1.01M | -2.05M | -3.35M | -1.19M | -1.08M |
| Financing Cash Flow | 1.12M | 3.52M | 6.57M | 9.48M | 5.68M | 2.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £31.18B | 5.98 | 19.40% | 5.00% | -2.83% | -40.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £896.49M | 43.61 | 9.32% | 2.11% | -6.03% | 13.11% | |
54 Neutral | £56.60M | -32.71 | -6.01% | ― | ― | ― | |
47 Neutral | £22.30M | -2.40 | ― | ― | 0.43% | 15.06% | |
41 Neutral | £915.21K | -0.96 | -21.81% | ― | -25.00% | 52.94% |